416 related articles for article (PubMed ID: 28517434)
1. SU-E-T-481: Dosimetric Effects of Tissue Heterogeneity in Proton Therapy: Monte Carlo Simulation and Experimental Study Using Animal Tissue Phantoms.
Liu Y; Zheng Y
Med Phys; 2012 Jun; 39(6Part17):3815-3816. PubMed ID: 28517434
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking a GATE/Geant4 Monte Carlo model for proton beams in magnetic fields.
Padilla-Cabal F; Alejandro Fragoso J; Franz Resch A; Georg D; Fuchs H
Med Phys; 2020 Jan; 47(1):223-233. PubMed ID: 31661559
[TBL] [Abstract][Full Text] [Related]
3. Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.
Parodi K; Ferrari A; Sommerer F; Paganetti H
Phys Med Biol; 2007 Jun; 52(12):3369-87. PubMed ID: 17664549
[TBL] [Abstract][Full Text] [Related]
4. Experimental depth dose curves of a 67.5 MeV proton beam for benchmarking and validation of Monte Carlo simulation.
Faddegon BA; Shin J; Castenada CM; Ramos-Méndez J; Daftari IK
Med Phys; 2015 Jul; 42(7):4199-210. PubMed ID: 26133619
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of using fall-off gradients of early and late PET scans for proton range verification.
Cho J; Grogg K; Min CH; Zhu X; Paganetti H; Lee HC; El Fakhri G
Med Phys; 2017 May; 44(5):1734-1746. PubMed ID: 28273345
[TBL] [Abstract][Full Text] [Related]
6. SU-E-T-495: Monte Carlo Dose Verification of Passive Scattering Proton Therapy for Prostate Cancer.
Giantsoudi D; Paganetti H
Med Phys; 2012 Jun; 39(6Part17):3819. PubMed ID: 28517455
[TBL] [Abstract][Full Text] [Related]
7. Effects of Hounsfield number conversion on CT based proton Monte Carlo dose calculations.
Jiang H; Seco J; Paganetti H
Med Phys; 2007 Apr; 34(4):1439-49. PubMed ID: 17500475
[TBL] [Abstract][Full Text] [Related]
8. SU-E-T-400: SBRT Dose Verification Using Monte Carlo Simulation.
Luo W; Xie X; McGarry R; Molloy J
Med Phys; 2012 Jun; 39(6Part16):3796. PubMed ID: 28517221
[TBL] [Abstract][Full Text] [Related]
9. An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.
Bueno M; Paganetti H; Duch MA; Schuemann J
Med Phys; 2013 Aug; 40(8):081704. PubMed ID: 23927301
[TBL] [Abstract][Full Text] [Related]
10. SU-E-T-470: Comparison of Proton Treatment Planning and Monte Carlo Calculation Using TOPAS for Liver Cancer.
Moteabbed M; Schuemann J; Paganetti H
Med Phys; 2012 Jun; 39(6Part17):3813. PubMed ID: 28517462
[TBL] [Abstract][Full Text] [Related]
11. Technical Note: Experimental verification of magnetic field-induced beam deflection and Bragg peak displacement for MR-integrated proton therapy.
Schellhammer SM; Gantz S; Lühr A; Oborn BM; Bussmann M; Hoffmann AL
Med Phys; 2018 Jul; 45(7):3429-3434. PubMed ID: 29763970
[TBL] [Abstract][Full Text] [Related]
12. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
[TBL] [Abstract][Full Text] [Related]
13. Advanced kernel methods vs. Monte Carlo-based dose calculation for high energy photon beams.
Fotina I; Winkler P; Künzler T; Reiterer J; Simmat I; Georg D
Radiother Oncol; 2009 Dec; 93(3):645-53. PubMed ID: 19926153
[TBL] [Abstract][Full Text] [Related]
14. GATE as a GEANT4-based Monte Carlo platform for the evaluation of proton pencil beam scanning treatment plans.
Grevillot L; Bertrand D; Dessy F; Freud N; Sarrut D
Phys Med Biol; 2012 Jul; 57(13):4223-44. PubMed ID: 22684098
[TBL] [Abstract][Full Text] [Related]
15. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
[TBL] [Abstract][Full Text] [Related]
16. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility.
Paganetti H; Jiang H; Lee SY; Kooy HM
Med Phys; 2004 Jul; 31(7):2107-18. PubMed ID: 15305464
[TBL] [Abstract][Full Text] [Related]
17. The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.
España S; Paganetti H
Phys Med Biol; 2010 Dec; 55(24):7557-71. PubMed ID: 21098912
[TBL] [Abstract][Full Text] [Related]
18. SU-E-T-435: Automatic Monte Carlo Dose Calculations of Proton Treatment Plans.
Titt U; Mirkovic D; Liu A; Mohan R
Med Phys; 2012 Jun; 39(6Part16):3805. PubMed ID: 28517181
[TBL] [Abstract][Full Text] [Related]
19. TOPAS Monte Carlo simulation for double scattering proton therapy and dosimetric evaluation.
Liu H; Li Z; Slopsema R; Hong L; Pei X; Xu XG
Phys Med; 2019 Jun; 62():53-62. PubMed ID: 31153399
[TBL] [Abstract][Full Text] [Related]
20. Experimental measurements and Monte Carlo simulations for dosimetric evaluations of intrafraction motion for gated and ungated intensity modulated arc therapy deliveries.
Oliver M; Gladwish A; Staruch R; Craig J; Gaede S; Chen J; Wong E
Phys Med Biol; 2008 Nov; 53(22):6419-36. PubMed ID: 18941277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
